PODCAST: European businesses glum on China, and AstraZeneca weighs spin-off for Chinese unit

By Doug Young & Rene Vanguestaine

The latest annual survey by the EU Chamber of Commerce in China shows revenue fell for more European businesses’ China operations last year. Is this a watershed moment for China’s economy, showing the days of western enthusiasm for investing in the country will never return to pre-covid levels? And AstraZeneca has become the latest major company to weigh a potential spinoff of its China unit. Is this the beginning of a trend?

About China Inc

China Inc by Bamboo Works discusses the latest developments on Chinese companies listed in Hong Kong and the United States to drive informed decision-making for investors and others interested in this dynamic group of companies.

Subscribe to China Inc on your favorite app:

Apple Podcasts Spotify

,
, ,

Related Articles

RELATED ARTICLES

  1. AstraZnenca tax probe
    AstraZeneca could face limited fallout from Chinese tax probe
    AZN.US
  2. McKinsey Weighs China Exit, and Shenzhen Rescues Vanke
    2202.HK 000002.SHE
  3. A Shifting IPO Tide, and China Stocks Get Cold Shoulder in Europe
  4. NEWS WRAP: Profit plunges at JinkoSolar’s main China-listed unit
    JKS.US 688223.SHG
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

Autohome sells cars, a consumer product

BRIEF: Autohome slashes headcount as revenue sags

Car-trading services provider Autohome Inc. (ATHM.US; 2518.HK) on Thursday reported its revenue slumped 10% in the first quarter, as the company cut about a fifth of its workforce over the…
2518.HK ATHM.US